Lupin Ltd. (LUPIN) Share Price Rises 2.52% to Rs 2,144.70 on the Day
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Lupin Ltd. Share Price rose 2.52% to Rs 2,144.70, with market capitalisation at Rs 93,611.47 Cr. The stock opened at Rs 2,090.60, touched Rs 2,144.70, and closed its latest traded point at the day high.
Lupin Share Price is in focus after the stock rose 2.52% to Rs 2,144.70, adding Rs 52.70 from the previous close of Rs 2,092.00. The company’s market capitalisation now stands at Rs 93,611.47 Cr, keeping Lupin among the larger names in the healthcare universe by market value. Today’s move in Lupin Share Price Today is relevant because it came without any company-specific catalyst in the supplied data, so the verified numbers themselves define the event. The move also matters because the stock traded between Rs 2,079.00 and Rs 2,144.70, placing the latest price at the day’s high. In this Lupin Stock News update, Univest tracks the move through price, valuation, sector context and company fundamentals rather than speculation.
Lupin Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,144.7 |
| Previous Close | Rs 2,092 |
| Today's Move | Rs 52.7 (+2.52%) |
| Open | Rs 2,090.6 |
| High | Rs 2,144.7 |
| Low | Rs 2,079 |
| Turnover | Rs 28.82 crore |
| Market Capitalisation | Rs 93,611.47 crore |
| Market Cap Category | Large Cap |
Lupin Ltd. (LUPIN) rose to Rs 2,144.7 from the previous close of Rs 2,092, a move of Rs 52.7 or 2.52%. The stock opened at Rs 2,090.6, reached a high of Rs 2,144.7, recorded a low of Rs 2,079.
Lupin Share Price Today moved from an opening level of Rs 2,090.60 to Rs 2,144.70, which is Rs 52.70 above the previous close of Rs 2,092.00. The stock’s intraday low was Rs 2,079.00, while the intraday high matched the latest price at Rs 2,144.70. Turnover stood at Rs 28.82 Cr, giving a factual traded-value reference for the session. This makes Lupin a notable name in Stock Market Today and among Stocks in News even though the supplied data does not establish a company-specific trigger. For readers tracking Lupin Share Price, the key point is straightforward: the session ended with a clear share price rise and a higher traded value point than the previous close. Univest presents this as verified price action, not as a reasoned guess about what caused it.
Lupin Ltd. (LUPIN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 93,611.47 crore |
| P/E Ratio | 17.3x |
| P/B Ratio | 4.02x |
| ROE | 27.11% |
| ROCE | 28.86% |
| EPS | Rs 120.91 |
| Book Value Per Share | Rs 520.51 |
| Dividend Yield | 0.86% |
Lupin Ltd. (LUPIN) fundamental metrics show P/E 17.3x, P/B 4.02x, ROE 27.11%, ROCE 28.86%. These figures provide context only and are not a buy or sell signal.
Lupin Ltd. has a market capitalisation of Rs 93611.47 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 17.3x, P/B at 4.02x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.11% and ROCE of 28.86%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 120.91, book value per share of Rs 520.51, dividend yield of 0.86%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 17.3x |
| Benchmark Median P/E | 32.69x |
| Benchmark Average P/E | 44.72x |
| Benchmark P/E Range | 3.44x to 417.17x |
| Company P/B Ratio | 4.02x |
| Benchmark Median P/B | 3.1x |
| Company ROE | 27.11% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 28.86% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 93,611.47 crore |
| Benchmark Median Market Cap | Rs 741.38 crore |
Lupin Ltd. (LUPIN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Lupin Ltd. (LUPIN) has a P/E ratio of 17.3x, which is below the benchmark median of 32.69x, a difference of -47.08%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Lupin Ltd. (LUPIN) has a ROE of 27.11%, which is above the benchmark median of 11.78%, a difference of +130.14%. Lupin Ltd. (LUPIN) has a ROCE of 28.86%, which is above the benchmark median of 13.65%, a difference of +111.43%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 37.01 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,223.13 | 84.83 | 14.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,83,453.32 | 85.3 | 20.73 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,10,224.17 | 25.14 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,09,848.55 | 32.89 | 3.15 | 11.83 | 16 |
Lupin Ltd. (LUPIN) has a P/E ratio of 17.3x compared with the displayed peer median of 37.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.11% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 28.86% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Lupin Ltd. (LUPIN) has a market capitalisation of Rs 93,611.47 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Lupin
- Lupin Share Price rose 2.52% to Rs 2,144.70 from Rs 2,092.00 in the latest session.
- The stock’s day range was Rs 2,079.00 to Rs 2,144.70, with the latest price matching the day high.
- Market capitalisation stands at Rs 93,611.47 Cr, which places Lupin well above the same-industry median.
- PE is 17.3, PB is 4.02, ROE is 27.11 and ROCE is 28.86, giving a full valuation and return snapshot.
- EPS of Rs 120.91, book value of Rs 520.51 and dividend yield of 0.86 add extra company context for Lupin Share Price.
About Lupin Ltd.
Lupin Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is known for pharmaceutical products and related healthcare offerings, and its listing on NSE and BSE makes Lupin Share Price relevant to investors who track the Indian stock market closely. In the supplied dataset, the focus is on financial and market metrics rather than a detailed product breakup, so the company overview stays limited to verified business classification and market positioning.
From a reporting perspective, Lupin’s scale is visible through its market capitalisation of Rs 93,611.47 Cr, while its profitability ratios show strong returns on equity and capital employed. That combination gives Lupin Stock News and Lupin Share Price Today continued relevance in market updates. Univest covers the company as part of the healthcare universe, where valuation, earnings quality and peer comparison are often central to stock analysis and fundamental analysis.
Track Lupin Share Price on Univest
Use Lupin Ltd. (LUPIN) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Lupin Share Price on Univest for live price updates, share price news, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers compare Lupin Share Price Today with peer valuations, sector benchmarks and company financials in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Lupin Share Price rise today?
Ans. The supplied data confirms that Lupin Share Price rose 2.52% today, but it does not establish a company-specific catalyst. The move is visible in the price action, with the stock finishing at Rs 2,144.70.
What is Lupin Share Price Today?
Ans. Lupin Share Price Today is Rs 2,144.70. It gained Rs 52.70 from the previous close of Rs 2,092.00 and traded between Rs 2,079.00 and Rs 2,144.70 during the session. The previous close was Rs 2,092.
What is Lupin’s market capitalisation?
Ans. Lupin’s market capitalisation is Rs 93,611.47 Cr. In the same-industry benchmark, that is far above the median of Rs 741.38 Cr and the average of Rs 13,917.82 Cr. The company operates in the Healthcare sector.
How does Lupin compare on valuation with peers?
Ans. Lupin’s PE ratio of 17.3 is lower than every peer listed in the supplied comparison set. Its PB of 4.02 is also below many peers, while ROE and ROCE are among the strongest shown.
What do Lupin’s EPS and book value show?
Ans. Lupin reports EPS of Rs 120.91 and book value of Rs 520.51. EPS shows earnings attributable to each share, while book value per share reflects accounting net worth behind each share.
Does Lupin pay a dividend?
Ans. Yes, the supplied dividend yield is 0.86. Dividend yield reflects historical payout relative to the current price, so it is useful as context but not a guarantee of future payouts.
How does Lupin stand in the healthcare sector?
Ans. Lupin operates in Healthcare and Pharmaceuticals & Drugs. Its ROE of 27.11 and ROCE of 28.86 are above the same-industry median and average, which adds financial context to today’s share price rise.
Where can I track Lupin Share Price and stock news?
Ans. Univest tracks Lupin Share Price, Lupin Stock News and related fundamentals in one place. Readers can review live price updates, valuation ratios, shareholding pattern and sector comparison alongside the day’s market move.
